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The function of the c-myc protein, the product of a proto oncogene, is not clearly understood although many reports, including ours, suggest hat 
the c-myc protein plays several roles in the regulation of transcription and DNA replication. Here we examined the effects of c-myc protein on 
transcription from the c-myc promoter, and by inference its role in auto-regulation, after introducing into cultured cells a c-myc expression vector 
and a CAT reporter gene linked to the promoter and upstream region of the human c-myc gene. To minimize the effects of the endogenous c-myc 
protein on the exogenously added CAT reporter gene, the transfected cells were treated under serum-free conditions. The results show that CAT 
expression from the myc promoter increased in a dose-dependent manner Efter addition of the c-myc expression vector, and that it also required 
the presence of a c-myc binding sequence previously identified 2 kb upstream from c-myc’s first exon.Moreover, the domains of the c-myc protein 
important for transactivation were determined by use of various deletions mutants of c-myc DNA. The results showed that the N-terminal portion 
in the c-myc protein was necessary for transactivation beside the C-terminal portion containing basic region, helix-loop-helix, and leucine zipper. 
c-myc; Autoregulation; Activation 
1. INTRODUCTION 
The c-myc protein, a nuclear oncogene product, has 
been considered to have an important role for cell pro- 
liferation. Although many reports suggest that the c- 
nzyc protein is directly or indirectly involved in tran- 
scription and/or DNA replication, there is still no 
strong consensus about its molecular functions (for re- 
views see [l-4]). As for its transcriptional functions, it 
was reported that c-nlyc protein activated the heat 
shock 70(HSP70) promoter and repressed the metal- 
lothionein promoter [5,6], and that the adenovirus E4 
promoter could be transactivated by the c-myc protein 
through the same promoter region required for Ela 
activation [7]. Recently, using a c-myc-steroid receptor 
fusion protein that permits hormone-dependent myc ac- 
tivity [S], a myc-inducible transcript has been identified 
which is related to the cz-prothymosin gene [S]. On the 
other hand, the autoregulation of c-myc has been also 
studied, albeit with controversial results. 
system used for the assays; cells, time of transfection, 
amount of C-myc, and so on. Here we report that the 
expression from the c-myc promoter in its natural con- 
text was regulated by the c-myc protein itself in a dose- 
dependent manner, that it required the presence of a 
c-myc binding region upstream of the promoter, and 
also that the N-terminal portion as well as the c-termi- 
nal of the c-myc protein were important for transaetiva- 
Down-regulation of c-myc [IO, 112, Q: up-regulaticn 
[K&14] after introduction of exogenous myc have been 
reported. These discrepancies are likely to be due to the 
Abbreviations: CAT, chloramphenicol acetyl transferase; MEM, mini- 
mal essential medium. 
*Present address: The Institute of Medical Science, The University of 
Tokyo, 4-6-1, Shirokanedai, Minato-Ku, Tokyo, 108, Japan. 
Correspondence address: H. Ariga, Faculty of Pharmaceutical Scien- 
ces, Hokkaido University, Kita-ku, Kita I2 Nishi 6, Sapporo 060, 
Japan. Fax: @I) (11) 707 4490. 
Published by Elsevier Science Publishers B. V. 
tion. 
2. MATERlAES AND METHODS 
2. I, Plasmid construcrions 
The c-myc expression vector, pSVc-myc , was constructed as fol- 
lows. c-myc cDNA, cloned in pSPTG4 [ 151, was first digested with SplzI 
and BarnHI, treated with exonuclease III followed by mungbean nu- 
clease, and then self-ligated. A resulting clone that contained the 
sequence from -33 to the 3’-end of thee-myc cDNA was digested with 
Hind111 and EcoRI, and the fragment containing the c-myc gene was 
inserted into the IJindIII-&oRI sites of pSV0. The latter consists of 
the SV40 enhancer and promoter cloned in pBR322 [l6]. The two 
reporter genes, pHX-CAT and pPX-CAT were constructed with the 
region upstream of the protein coding sequences of the genomic 
human c-myc DNA . A c-myc protein binding sequence is present 
between the Hi&Ii1 and PsrI sites about 2 kbp upstream of the 
transcription initiation site, while c-myc’s promoters PI and P2 are 
located within the first exon. The 610 bp long SmoI-PvuII fragment 
(which contains c-my& first exon) was inserted upstream of the bac- 
terial chloramphenicol acetyl transferase gene (CAT), yielding 
pEXONI-CAT. pHXCAT was constructed by joining the c-myc 
gene’s HindIII-SmaI region upstream thereof. Analogously, pPX- 
CAT was constructed by junction of the relative PsrI-SmaI fragment. 
2.2. Cell culture and transfrction 
Human Heka, mouse L, Balb 3T3, and monkey CosI cells were 
cultured in Dulbecco modified Eagle MEM supplemented with 10% 
fetal calf serum. 5 pg of CAT reporter plasmid and various amounts 
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Fig. 1. Effect of c-myc protein on CAT expression in mouse L cells. pHXCAT, which contains the region upstream of the c-myc gene was 
co-transfected with a c-myc expression vector, pSVc-myc, or the vector pSV0, into mouse L cells. Cells were cultured with (A) or without serum 
(B) 16 h after transf’ection. pPXCAT which corresponds to pHXCAT without he HindIII-PslI region of human the c-myc gene was also transfected 
in to L cells, and the cells were cultured without serum. pSV2CAT, which harbours the SV40 promoter and enhancer was used as a positive control 
of CAT expression. CAT assays were carried out as in section 2. The results from one of the CAT assays are shown in the photograph and the 
relative CAT activities of the test amples (the lowest CAT activity among the activities of the test amples was set as relative value 1) were shown 
above the autoradiograph. Bars in the graph represent the variations af 3 independent experiments. 
of pSVc-myc were contransfected into 100 mm-diameter plates (50% 
contluent cells) by the calcium phosphate precipitation technique (17). 
Four hours after transfection, the cells were boosted with 25% glyce- 
rol, cultured for 15 h with 10% fetal calf serum, eventually cultured 
for another 24 h without serum, and then harvested. The CAT assay 
using cell extracts has been described previously [18]. Quantification 
of the relative CAT activities was performed by use of a Bioimage 
image analyzer. 
zed. To this purpose, various cell types were transfected 
with a c-myc expression vector, pSVc-myc, and with the 
reporter plasmid pHXCAT which contains the region 
upstream of the coding sequence in the human c- myc 
gene. Nineteen hours after transfection, the cells were 
cultured with, respectively without serum, and CAT 
assays were carried out , Cells cultured without serum 
expressed little endogenous c-myc , as deduced from an 
Sl mapping (data not shown). The absolute CAT ac- 
3. RESULTS tivities obtained varied with the cell types: as an exam- 
ple, the results from mouse L and monkey CosI cells are 
3.1. Establishment of a system to detect the transcriptio- 
nal activity of exogenously added c-myc 
Numerous controversial results about c-myc tran- 
scriptional activity reported so far are likely to be due 
to different experimental conditions including cell type, 
cell condition, transfection methods, and so on. An im- 
portant point is also that the effect seen on transcriptio- 
nal events is likely to be derived from the combined 
action of endogenous and exogenous c-myc protein. To 
see the effect of the exogenously added c-myc on tran- 
scription, the level of the endogenous hould be minimi- 
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shown in Figs 1 and 2, respectively. Wowever, the 
patterns of activation were similar ir. all ce!? types 
iested. Basically, transcriptional activation occurred 
with low levels of c-myc , while increased amounts of 
c-myc led to suppression in the cells cultured without 
serum. In the cells with serum, on the other hand, only 
suppression could be seen, in all cell types. Difference 
of the activation range observed is likely to be due to 
the strength of the SV4Q promoter in two cells. In fact, 
while in L-cells activation occurred with l-2 ,ug pSVc- 
m,yc. only as little as 0.2-l lug were needed in CosI cells, 
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Fig. 2. Effect of the c-myc protein on CAT expression i  monkey Cod cells. pHXCAT was transfected into monkey CosI cells. The cells were 
cultured with (A) or without serum (B and B’), and CAT assays were carried out as in Fig. 1. Fig. B’ is a complement to Fig. B, in that it shows 
the transcriptional ctivation patterns obtained with small increases of pSVc-myc from 0 to 2 pg. 
serum(-) 
where amounts greater than 1 ,~g already inhibited tran- 
scription. 
tion machinery, for instance by competing for transcrip- 
tion factors. 
The range where activation occurs was relatively wide 
in L cells cultured without serum. The L cells/serum-free 
combination was therefore used in all subsequent expe- 
riments. 
Oddly, the basal level of the reporter plasmid alone, 
3.2. Importance of the spect@ic interaction between c-~1yc 
protein and DNA 
pHXCAT, always seemed slightly higher than that of 
the same pl-IXCAT co-transfected with vector pSV0 or 
with pSVQ-derived expression vectors for inactive dele- 
tion mutants of c-myc (see below). We think this may 
happen because of the presence of SV40 enhancer/pro- 
moter sequences in pSVQ and its derivatives. These 
sequences possib!y interfere with the cellular transcrip- 
The reporter plasmid used in the CAT assays covered 
the region from HindIII to PvuII sites of the c-myc gene. 
We have already suggested that the c-myc protein, or a 
complex including the c-myc protein, binds to the region 
from HindI to PstI ((I-I-P) region) of the c-myc gene. 
As a control, pPXCAT (which corresponds to PI-IX- 
CAT without the ((H-P) region) was constructed, and 
the function of the c-myc promoter in this context was 
again tested (Fig. 1C). The results showed that in this 
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Fig. 3. Determination of the transactivation domain of the c-myc protein. Various deletion mutants of pSVc-myc were constructed; the regions 
deleted are shown in the figure. CAT expression of pHXCAT as affected by 1 ,~ug of deleted pSVc-myc clones was tested in L cells and the relative 
CAT activity as compared to that of pHXCAT alone (value 10.0) was shown on the left of the figuee. 
case c-myc had little effect on CAT expressisn, sug- 
gesting that the target of the c-myc protein in pHXCAT 
was indeed the (H-P) region. 
3.3. Identification of the tramactivation domains of the 
c-mye protein 
The c-myc protein possesses everal interesting do- 
mains which may affect ransaetivating fun&ions. Dele- 































Fig. 4. Determination of the precise transactivation d main of the c-myc protein. Various deletion mutants of pSVc-myc were constructed, and-their 
effect on CAT expression of pNXCAT was tested as in Fig, 3. The relative CAT activities of the test samples as compared to that of pHXCAT 
alone (value 10.0) are shown. 
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were constructed (Figs 3 and 4) and assayed for their 
transactivating function on a reporter plasmid contain- 
ing the c-myc promoter. Experiments were repeated at 
least 3 times, and the relative CAT activities were 
shown. It is clear that deletions from amino acid No. 48 
to 102 and 101 to 167 gave weak activities, indicating 
that the N-terminal portion is important for activation. 
There also exists important regions near the C-terminus 
of the c-myc protein: basic region, helix-loop-helix 
(HIM), and leucine zipper region. Mutants lacking 
these domains also lost activity, suggesting that DNA 
binding of the c-)y~yc protein and/or protein-protein in- 
teractions are necessary. On the other hand, the portion 
between amino acids 156 to 263 seemed to be dis- 
pensable for transactivation. 
tial domain was found near the N-terminus, in particu- 
lar between amino acids 41-167, where there exists a 
region highly conserved in the myc family. This is consi- 
sten.t with another report [%O] that an activation domain 
spans amino acids 1 to P43. Results presented here also 
identified as essential the region close to the C-terminus, 
which contains basic region, HEH and leucine zipper 
structures. These are considered to be mecessary for 
specific DNA binding and protein-protein complex for- 
mation. As a matter of fact, both N- and C-terminal 
regions are important for oncogenic transformation 
[21,X]. On the other hand, the region between amino 
acids 156 to 263 seemed to be dispensable. This region 
comprises an acidic domain. 
4. DISCIJSSION 
In this work we have attempted to investigate the role 
of the c-myc protein in the regulation of transcription 
from its own promoter and upstream regulatory se- 
quences. A condition essential for this purpose was to 
minimize the effects of the endogenous c-myc protein. 
We have achieved this goal by culturing the cells in 
serum-free conditions several hours after transfection. 
The results show that transcription from the c-myc 
promoter can be induced by co-transfection of a c-myc 
protein expression vector. Transcriptional activation 
was found to take place with low amounts of c-myc, it-r 
a dose-dependent manner. Increasing amounts of c-myc 
protein led instead to inhibition of transcription, which 
is consistent with the fact that only inhibition effects 
could be seen, with any amount of c-myc expression 
vector, in the cells cultured with serum (that is, which 
already contain high levels of endogenous c-myc). In 
addition, transactivation seemed to depend on the pres- 
ence of the (II-P) sequence, which is located about 2 
kb upstream of c-myc’s first exon and contains a specific 
binding site for the c-myc protein (alone or in complex 
form). In fact, no effect on transcription could be seen 
with a reporter gene that lacked the (II-P) region. These 
results strongly suggest that c-myc autoregulates its own 
expression. It was reported that the a-prothymosin is 
activated by the c-myc protein at the entry into and 
progression through the cell-cycle [S]. It was also repor- 
ted that the nuclear localization of the c-myc protein in 
the lower eukaryote Physarum polycephalum changed 
during the cell cycle, being transiently but specifically 
bound to the periphery of the nuclear matrix, where 
DNA replication and transcription are thought to take 
place, during the S-phase [19]. It is therefore possible 
that the trans-acting effect of c-myc on its own expres- 
sion may somehow be related to the cell cycle: activa- 
tion would occur in the period between 61 and S phases 
or immediately after entry of the S phase. 
As mentioned above, the tram-acting function of the 
c-myc protein may require its binding to a specific target 
sequence (see also refs 11%141). On one side, we have 
already reported the existence of a c-myc binding se- 
quence in the (II-P) region upstream of the c-myc gene 
itself ([ 131, Negishi, Iguchi-Ariga and kriga, submitted). 
On the other hand, a distinct sequence was recently 
reported [23,24], where the c-myc protein can specifi- 
cally bind in heterodimeric association with a novel 
myc-associated protein (MAX) [24]. Latest experiments 
of ours showed that the c-myc protein complex can 
indeed bind to either sequence, and that its binding to 
the one can be competed-out by the other (Negishi et al., 
submitted). These data indicate that c-myc plays mani- 
fold roles in cellular life. Transcriptional functions of 
the c-myc protein will be further elucidated with more 
biochemical approaches. For this purpose, we envisage 
in vitro assays with the purified, biologically active c- 
myc protein that we have enriched from human cells by 
use of an affinity column carrying the c-n~yc binding 
core sequence present in myc (H-P) (Negishi et al., sub- 
mitted; Taira, Negishi, Kihara, Iguchi-Ariga and Ariga, 
submitted) and also DNA cloning encoding c-myc as- 
sociated proteins. These experiments will dissolve the 
question that c-myc protein directly or indirectly activa- 
tes the gene expression. 
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